Rhumbline Advisers X Biotech Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in X Biotech Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 21,250 shares of XBIT stock, worth $141,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,250

Previous 20,094 5.75%

Holding current value

$141,525

Previous $103,000 59.22%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$5.55 - $7.95 $6,415 - $9,190	1,156 Added 5.75%	21,250 $164,000
Q2 2024 Aug 01, 2024	BUY	$4.54 - $9.89 $87,808 - $191,282	19,341 Added 2568.53%	20,094 $103,000
Q2 2023 Aug 08, 2023	BUY	$3.06 - $6.38 $2,304 - $4,804	753 New	753 $4,000
Q2 2022 Aug 11, 2022	SELL	$5.13 - $9.2 $96,177 - $172,481	-18,748 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$8.64 - $11.71 $16,951 - $22,975	-1,962 Reduced 9.47%	18,748 $162,000
Q4 2021 Feb 10, 2022	SELL	$10.95 - $16.07 $5,858 - $8,597	-535 Reduced 2.52%	20,710 $231,000
Q3 2021 Nov 12, 2021	BUY	$12.95 - $18.24 $11,137 - $15,686	860 Added 4.22%	21,245 $275,000
Q2 2021 Aug 05, 2021	SELL	$15.83 - $17.84 $29,190 - $32,896	-1,844 Reduced 8.3%	20,385 $338,000
Q1 2021 May 06, 2021	SELL	$15.92 - $20.3 $10,825 - $13,804	-680 Reduced 2.97%	22,229 $382,000
Q4 2020 Feb 10, 2021	BUY	$15.65 - $19.92 $49,000 - $62,369	3,131 Added 15.83%	22,909 $359,000
Q3 2020 Nov 12, 2020	SELL	$13.97 - $21.16 $46,380 - $70,251	-3,320 Reduced 14.37%	19,778 $378,000
Q2 2020 Aug 13, 2020	BUY	$10.39 - $16.07 $69,228 - $107,074	6,663 Added 40.54%	23,098 $317,000
Q1 2020 May 06, 2020	SELL	$8.89 - $24.94 $22,269 - $62,474	-2,505 Reduced 13.23%	16,435 $175,000
Q4 2019 Feb 05, 2020	BUY	$8.33 - $19.95 $43,890 - $105,116	5,269 Added 38.54%	18,940 $354,000
Q3 2019 Oct 23, 2019	BUY	$6.86 - $10.46 $3,087 - $4,707	450 Added 3.4%	13,671 $143,000
Q2 2019 Aug 14, 2019	BUY	$6.99 - $11.27 $92,414 - $149,000	13,221 New	13,221 $100,000
Q2 2018 Aug 06, 2018	SELL	$4.04 - $5.13 $70,178 - $89,113	-17,371 Closed	0 $0
Q1 2018 May 02, 2018	SELL	$3.92 - $5.35 $1,176 - $1,605	-300 Reduced 1.7%	17,371 $93,000
Q3 2017 Nov 06, 2017	BUY	$4.14 - $5.12 $73,157 - $90,475	17,671	17,671 $77,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.87M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers X Biotech Inc. Transaction History